Loading company
$14.71-0.6%Nov 13 close
Figures through June 30, 2026, from the 6-K filed September 17, 2026
Past performance
- 1W
- -4.7%
- 1M
- +0.1%
- 3M
- -22.6%
- 6M
- -24.6%
- 1Y
- -57.1%
$14.71-0.6%Nov 13 close
Figures through June 30, 2026, from the 6-K filed September 17, 2026
From the company’s own 6-K filing.
The quote and the company description come from the 6-K Ascentage Pharma Group International filed on September 17, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Ascentage Pharma Group International has no earnings call transcript available.